Musa A. Wadi, MD

78% more Medicare Part D claims than the average critical care medicine (internal medicine) physician in 2024

1,239 Medicare Part D claims for 192 beneficiaries, against an average of 696 among the 2,873 providers of this specialty who prescribed in Part D. Brand-name drugs were 61% of claims.

Most prescribed

1. Trelegy Ellipta209 claims
2. Montelukast Sodium185 claims
3. Albuterol Sulfate Hfa135 claims
4. Breztri Aerosphere96 claims
5. Spiriva Respimat79 claims
6. Breo Ellipta75 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

The practice group's MIPS final score for 2023 (Medicare payment program): 97.4 of 100

The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.

Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).

Industry payments in 2024: $1,640.23

88 payments; by number, the most common kind was food and beverage; the largest payer was GlaxoSmithKline, LLC. The 2,708 providers of this specialty with any payment received $2,958.68 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.

Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.

Bills Medicare through 2 group practices

1. Critical Care Specialists OF North Texas PLLCWichita Falls, TX
2. Pulmonary Services OF North Texas PLLCWichita Falls, TX

Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).